❌

Normal view

Received — 27 May 2026 ⏭ Journals

Liver-specific <i>SIRT1</i> knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2

✇Oncogene - Issue - nature.com science feeds
By: Yiwei Cao · Jingyi Wei · Qiang Chen · Haitao Wang · Jiao Mu · Shuhan Lu · Menghui Yuan · Mohammed A. El-Magd · Bichan Xu · Ruihong Wang · Peng Yuan
24 May 2026 at 08:00

Oncogene, Published online: 24 May 2026; doi:10.1038/s41388-026-03826-5

Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2

Accelerating scientific discovery with Co-Scientist

✇Nature - Issue - nature.com science feeds
By: Juraj Gottweis · Wei-Hung Weng · Alexander Daryin · Tao Tu · Petar Sirkovic · Artiom Myaskovsky · Grzegorz Glowaty · Felix Weissenberger · Alessio Orlandi · Dan Popovici · Anil Palepu · Keran Rong · Ryutaro Tanno · Khaled Saab · Fan Zhang · Jacob Blum · Andrew Carroll · Kavita Kulkarni · Nenad Tomašev · Dina Zverinski · Ivor Rendulic · Elahe Vedadi · Florian Hasler · Luka Rimanic · Marina Boia · Ivan Budiselic · Ben Feinstein · Mathias Bellaiche · Tom Sheffer · Jan Freyberg · Jeremy Ratcliff · Ottavia Bertolli · Katherine Chou · Avinatan Hassidim · Burak Gokturk · Amin Vahdat · Yuan Guan · Vikram Dhillon · Eeshit Dhaval Vaishnav · Byron Lee · Tiago R. D. Costa · José R. Penadés · Gary Peltz · Yossi Matias · James Manyika · Demis Hassabis · Yunhan Xu · Pushmeet Kohli · Annalisa Pawlosky · Alan Karthikesalingam · Vivek Natarajan
19 May 2026 at 08:00

Nature, Published online: 19 May 2026; doi:10.1038/s41586-026-10644-y

Accelerating scientific discovery with Co-Scientist

Mapping convergent regulators of melanoma drug resistance by PerturbFate

✇Nature - Issue - nature.com science feeds
By: Zihan Xu · Ziyu Lu · Aileen Ugurbil · Abdulraouf Abdulraouf · Andrew Liao · Jianxiang Zhang · Wei Zhou · Junyue Cao
15 April 2026 at 08:00

Nature, Published online: 15 April 2026; doi:10.1038/s41586-026-10367-0

PerturbFate is a high-throughput, cost-effective, single-cell platform that systematically profiles CRISPR interference perturbations to reveal common regulatory nodes and convergent phenotypic states across diverse genetic alterations linked to vemurafenib resistance in melanoma cells.
Received — 13 April 2026 ⏭ Journals

The importance of competition and facilitation for global tree diversity

✇Nature - Issue - nature.com science feeds
By: Han Xu · Matteo Detto · J. Aaron Hogan · Alfonso Alonso · Joseph D. Birch · Pulchérie Bissiengou · Chengjin Chu · Stuart J. Davies · Gunter A. Fischer · Billy C. H. Hau · David Kenfack · Buhang Li · Juyu Lian · Mingxian Lin · Wande Liu · Yu Liu · Zhifa Liu · James A. Lutz · Hervé Roland Memiaghe · Xiangcheng Mi · Vojtech Novotny · Haibao Ren · Jianrong Su · Jill Thompson · Maria Uriarte · Renato Valencia · Tze Leong Yao · Sandra L. Yap · Yicen Zhang · Jess K. Zimmerman · George D. Weiblen · Yide Li · Suqin Fang · Fangliang He
8 April 2026 at 08:00

Nature, Published online: 08 April 2026; doi:10.1038/s41586-026-10349-2

Across 17 forest plots (2.7 million trees, 5,400 species), competition dominated overall, but facilitation was relatively stronger near the equator and declined towards higher latitudes, partly linked to temperature, legumes, mycorrhizal associations and canopy nursing effect.
Received — 14 March 2026 ⏭ Journals
  • ✇Nature Cancer
  • A functional map of m<sup>6</sup>A sites in cancer Yalong Wang · Han Xu
    Nature Cancer, Published online: 13 March 2026; doi:10.1038/s43018-026-01137-yRNA N6-methyladenosine (m6A) is the most abundant internal RNA modification, yet its functional landscape in cancer remains poorly defined. A study now introduces a METTL3-based RNA base-editing screen that maps functional m6A sites and reveals m6A-dependent translational activation of the tumor suppressor CHD9 in prostate cancer and beyond.
     
  • 🏷️
  • ↗️

A functional map of m<sup>6</sup>A sites in cancer

✇Nature Cancer
By: Yalong Wang · Han Xu
13 March 2026 at 08:00

Nature Cancer, Published online: 13 March 2026; doi:10.1038/s43018-026-01137-y

RNA N6-methyladenosine (m6A) is the most abundant internal RNA modification, yet its functional landscape in cancer remains poorly defined. A study now introduces a METTL3-based RNA base-editing screen that maps functional m6A sites and reveals m6A-dependent translational activation of the tumor suppressor CHD9 in prostate cancer and beyond.
There are no more articles
❌